Dermatology at Huashan Hospital Shanghai | CMCS

Expert Skin Disease Care at One of China's Premier Academic Medical Centers

The Department of Dermatology at Huashan Hospital — affiliated with Fudan University — is one of China's most distinguished and research-active dermatology centers, with a national reputation for excellence in the diagnosis and management of skin tumors, inflammatory dermatoses, sexually transmitted infections, autoimmune skin diseases, and rare dermatological conditions. The department combines outstanding clinical expertise with a productive research program, offering international patients access to some of China's most eminent dermatologists and the latest evidence-based treatments for complex skin conditions.

For international patients seeking expert dermatology care in Shanghai — whether for skin cancer, severe psoriasis, atopic dermatitis, a sexually transmitted infection, or a rare and difficult-to-diagnose skin condition — Huashan Hospital's dermatology department represents one of the most compelling destinations in Asia. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Huashan Hospital's dermatology department is a national key clinical specialty operating dedicated inpatient dermatology wards, a comprehensive outpatient dermatology clinic, a dermatopathology laboratory, a phototherapy unit, a laser and aesthetic dermatology service, a sexually transmitted infection (STI) clinic, a skin cancer clinic, and subspecialty clinics for psoriasis, atopic dermatitis, autoimmune skin disease, and rare genodermatoses.

The department is particularly recognized for its expertise in skin tumors — including melanoma, cutaneous lymphoma, and rare skin cancers — and for its STI clinic, which is one of the busiest and most experienced in Shanghai. The department's dermatopathology laboratory provides expert histopathological interpretation of skin biopsies, including immunohistochemistry and molecular testing for skin tumor diagnosis and classification. Faculty members publish regularly in leading dermatology journals including Journal of Investigative Dermatology, British Journal of Dermatology, JAMA Dermatology, and Journal of the American Academy of Dermatology.

Conditions Treated

Skin Cancer & Oncological Dermatology

• Melanoma — Dermoscopy-guided diagnosis; surgical excision with appropriate margins; sentinel lymph node biopsy coordination; BRAF/MEK inhibitors (dabrafenib/trametinib, vemurafenib/cobimetinib) for BRAF-mutated melanoma; PD-1 immunotherapy (pembrolizumab, nivolumab) for advanced disease; adjuvant therapy coordination
• Basal Cell Carcinoma (BCC) — Surgical excision; Mohs micrographic surgery coordination; vismodegib and sonidegib for advanced or locally advanced BCC; photodynamic therapy for superficial BCC
• Squamous Cell Carcinoma (SCC) — Surgical excision; cemiplimab for advanced cutaneous SCC; radiation therapy coordination
• Merkel Cell Carcinoma — Avelumab and pembrolizumab immunotherapy; radiation therapy coordination
• Cutaneous T-Cell Lymphoma (CTCL) — Mycosis fungoides and Sézary syndrome; skin-directed therapies (NB-UVB, PUVA, topical nitrogen mustard); systemic therapy (bexarotene, mogamulizumab, brentuximab vedotin); extracorporeal photopheresis
• Cutaneous B-Cell Lymphoma — Rituximab and chemotherapy coordination with hematology
• Dermatofibrosarcoma Protuberans (DFSP) — Wide local excision; imatinib for locally advanced or metastatic disease
• Kaposi Sarcoma — HIV-associated and classic KS; liposomal doxorubicin and paclitaxel
• Actinic Keratosis & Field Cancerization — Photodynamic therapy, topical 5-FU, imiquimod, and ingenol mebutate

Inflammatory Skin Diseases

• Psoriasis — Mild to severe plaque psoriasis; biologic therapy (IL-17 inhibitors: secukinumab, ixekizumab, bimekizumab; IL-23 inhibitors: guselkumab, risankizumab, tildrakizumab; IL-12/23: ustekinumab; TNF inhibitors); JAK inhibitors (deucravacitinib); phototherapy (NB-UVB, PUVA)
• Atopic Dermatitis (Eczema) — Mild to severe AD; dupilumab, tralokinumab, and lebrikizumab for moderate-to-severe disease; JAK inhibitors (abrocitinib, upadacitinib, baricitinib); topical calcineurin inhibitors, PDE4 inhibitors, and JAK inhibitors
• Urticaria & Angioedema — Chronic spontaneous and inducible urticaria; omalizumab for antihistamine-refractory CSU
• Hidradenitis Suppurativa — Adalimumab, secukinumab, and bimekizumab; surgical management coordination
• Rosacea — Medical management (topical ivermectin, azelaic acid, brimonidine) and laser therapy
• Acne Vulgaris — Topical and systemic therapy; isotretinoin; hormonal therapy for female patients
• Alopecia Areata — JAK inhibitors (baricitinib, ritlecitinib) for severe alopecia areata and alopecia totalis/universalis
• Vitiligo — Ruxolitinib cream; NB-UVB phototherapy; systemic JAK inhibitors for extensive disease
• Contact Dermatitis — Patch testing for allergic contact dermatitis; occupational dermatology

Autoimmune Skin Diseases

• Pemphigus Vulgaris & Foliaceus — Anti-desmoglein antibody-guided diagnosis; corticosteroids, rituximab, and mycophenolate
• Bullous Pemphigoid — Anti-BP180/BP230 antibody-guided diagnosis; corticosteroids, doxycycline, and dupilumab
• Cutaneous Lupus Erythematosus — Discoid lupus, subacute cutaneous lupus; hydroxychloroquine and immunosuppression
• Dermatomyositis — Skin manifestations; myositis antibody panel; IVIG, rituximab, and JAK inhibitors
• Systemic Sclerosis (Skin) — Skin fibrosis and Raynaud's; multidisciplinary management with rheumatology
• Vasculitis (Cutaneous) — Leukocytoclastic vasculitis, IgA vasculitis, and cutaneous PAN

Sexually Transmitted Infections (STIs)

• Syphilis — Primary, secondary, latent, and tertiary syphilis; neurosyphilis; penicillin and alternative regimens; partner notification
• Gonorrhea — Uncomplicated and complicated gonorrhea; ceftriaxone therapy; drug-resistant gonorrhea management
• Chlamydia & Non-Gonococcal Urethritis — Doxycycline and azithromycin therapy
• Genital Herpes (HSV-1 & HSV-2) — Episodic and suppressive antiviral therapy; counseling
• Human Papillomavirus (HPV) & Genital Warts — Topical therapy, cryotherapy, and laser treatment; HPV vaccination
• Molluscum Contagiosum — Cantharidin, cryotherapy, and curettage
• Pubic Lice & Scabies — Topical permethrin and ivermectin therapy
• HIV Testing & Referral — Rapid HIV testing; PrEP counseling; referral to HIV/AIDS service

Rare & Genetic Skin Diseases

• Epidermolysis Bullosa — Genetic diagnosis and wound care management; beremagene geperpavec (B-VEC) gene therapy for DEB
• Ichthyosis — Genetic diagnosis and emollient therapy; retinoid therapy for severe forms
• Neurofibromatosis — Selumetinib for plexiform neurofibromas in NF1
• Tuberous Sclerosis — mTOR inhibitors (everolimus, sirolimus) for skin manifestations
• Mastocytosis — Cutaneous and systemic mastocytosis; avapritinib for advanced systemic mastocytosis
• Rare Inflammatory Dermatoses — Pyoderma gangrenosum, Sweet's syndrome, and other neutrophilic dermatoses

Phototherapy Program

Huashan's phototherapy unit offers the full range of light-based treatments for inflammatory and pigmentary skin conditions:

• Narrowband UVB (NB-UVB) — For psoriasis, vitiligo, atopic dermatitis, and mycosis fungoides
• PUVA (Psoralen + UVA) — For severe psoriasis, CTCL, and other conditions
• Targeted Phototherapy — Excimer laser for localized vitiligo and psoriasis
• Photodynamic Therapy (PDT) — For actinic keratosis, superficial BCC, and acne

Laser & Aesthetic Dermatology

Huashan's laser dermatology service offers evidence-based laser and energy-based treatments for medical dermatological indications:

• Vascular Lasers — Pulsed dye laser for port wine stains, hemangiomas, and rosacea
• Pigment Lasers — Q-switched Nd:YAG and picosecond lasers for melasma, post-inflammatory hyperpigmentation, and tattoo removal
• Ablative Lasers — CO2 and Er:YAG lasers for scar revision and skin resurfacing
• Hair Removal — Diode and Nd:YAG laser hair removal

Why International Patients Choose Huashan Dermatology

• Skin Cancer Expertise — Comprehensive management of melanoma, CTCL, and rare skin cancers with access to targeted therapy and immunotherapy
• Full Biologic Portfolio — Experience with all approved biologics and JAK inhibitors for psoriasis, atopic dermatitis, urticaria, and alopecia areata
• STI Expertise — One of Shanghai's busiest and most experienced STI clinics with expertise in drug-resistant gonorrhea and complex syphilis
• Rare Skin Disease Diagnosis — Expert dermatopathology and molecular testing for rare genodermatoses and unusual inflammatory dermatoses
• Integrated Autoimmune Care — Close collaboration with rheumatology and infectious disease for complex cases
• Cost-Effectiveness — World-class dermatology care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your skin disease history, biopsy reports, laboratory results, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate dermatologist based on your condition — skin cancer, psoriasis, atopic dermatitis, STI, autoimmune skin disease, or rare genodermatosis.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Huashan Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Diagnostic Support — Full coordination of skin biopsy, dermatopathology, immunofluorescence, molecular testing, and other required investigations.
8. Post-Treatment Follow-Up — Biopsy report translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert dermatology care in Shanghai — whether for skin cancer, psoriasis, atopic dermatitis, a sexually transmitted infection, an autoimmune skin disease, or a rare dermatological condition — CMCS can arrange a specialist consultation with Huashan Hospital's dermatology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com